Gene · 53369
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skin Carotenoid Level as an Alternative Marker of Serum Total Carotenoid Concentration and Vegetable Intake Correlates with Biomarkers of Circulatory Diseases and Metabolic Syndrome. | Nutrients | 2020 | 32575348 | PubTator, text mining | PubMed |
| Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism. | Curr Opin Lipidol | 2020 | 32520778 | PubTator, text mining | PubMed |
| Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response. | Biomolecules | 2020 | 32466286 | PubTator, text mining | PubMed |
| Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography. | J Atheroscler Thromb | 2020 | 32435010 | PubTator, text mining | PubMed |
| Apolipoprotein L1 (APOL1) Coding Variants Are Associated With Creatinine Rise After Cardiac Surgery. | J Cardiothorac Vasc Anesth | 2020 | 32434723 | PubTator, text mining | PubMed |
| Serum level of HDL particles are independently associated with long-term prognosis in patients with coronary artery disease: The GENES study. | Sci Rep | 2020 | 32424189 | PubTator, text mining | PubMed |
| Reconfiguring Nature's Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents. | Nanomaterials (Basel) | 2020 | 32397159 | PubTator, text mining | PubMed |
| Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities. | Adv Drug Deliv Rev | 2020 | 32389761 | PubTator, text mining | PubMed |
| The cross-sectional study of hepatic lipase SNPs and plasma lipid levels. | Food Sci Nutr | 2020 | 32341780 | PubTator, text mining | PubMed |
| High-Density Lipoprotein Cholesterol in Age-Related Ocular Diseases. | Biomolecules | 2020 | 32331355 | PubTator, text mining | PubMed |
| High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential. | Front Cardiovasc Med | 2020 | 32296714 | PubTator, text mining | PubMed |
| Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. | Int J Mol Sci | 2020 | 32290082 | PubTator, text mining | PubMed |
| Nutrition and physical activity intervention for families with familial hypercholesterolaemia: protocol for a pilot randomised controlled feasibility study. | Pilot Feasibility Stud | 2020 | 32266080 | PubTator, text mining | PubMed |
| High-density lipoproteins during sepsis: from bench to bedside. | Crit Care | 2020 | 32264946 | PubTator, text mining | PubMed |
| Types of acute phase reactants and their importance in vaccination. | Biomed Rep | 2020 | 32190302 | PubTator, text mining | PubMed |
| 2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders. | Arch Med Sci | 2020 | 32190133 | PubTator, text mining | PubMed |
| Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux. | Arterioscler Thromb Vasc Biol | 2020 | 32131613 | PubTator, text mining | PubMed |
| Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity. | Nutrients | 2020 | 32110861 | PubTator, text mining | PubMed |
| Short and long term effect of treatment non-pharmacological and lifestyle in patients with metabolic syndrome. | Diabetol Metab Syndr | 2020 | 32082424 | PubTator, text mining | PubMed |
| HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels. | Ann Lab Med | 2020 | 32067428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53369/papers?page=17